Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Frank Harmon currently holds 8,915 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Frank Harmon has been a net seller of SGNT stock. They have purchased $0 and sold $104.3K worth of shares.
J. Frank Harmon's most recent insider trade was on Aug 29, 2016, when they sold 8,915 shares at $21.75 per share.
J. Frank Harmon serves as Executive at Sagent Pharmaceuticals, Inc. (SGNT). They have executed 6 insider transactions totaling $104.3K over their tenure at the company.
J. Frank Harmon holds the position of Executive at Sagent Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
J. Frank Harmon has shown a selling trading pattern, with $0 in total purchases and $104.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by J. Frank Harmon was on Aug 29, 2016, when they sold $193.9K worth of SGNT shares. This transaction involved 8,915 shares at $21.75 per share.
J. Frank Harmon currently owns 8,915 shares of Sagent Pharmaceuticals, Inc. (SGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Frank Harmon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Frank Harmon has 6 Form 4 filings on record as an insider at Sagent Pharmaceuticals, Inc..
Set alerts for J. Frank Harmon and 40,000+ other insiders.